Acquired pure megakaryocytic aplasia: report of a single case treated with mycophenolate mofetil.
Acquired pure megakaryocytic aplasia (APMA) is a rare disorder in the field of hematological diseases. We report the case of a patient with APMA treated with mycophenolate mofetil and review the literature associated with this. Until today, very few cases of APMA have been reported and the disease etiology still seems to be unclear. There have been no reported cases of treatment of APMA treated with mycophenolate mofetil.
Bulchandani
Deepti
D
Department of Internal Medicine, University of Missouri-Kansas City, Kansas City, MO, USA. dbulchandani@yahoo.com
Nachnani
Jagdish
J
Belt
Robert
R
Hinton
Stuart
S
D000368:Aged; D001855:Bone Marrow Diseases / Q000188:drug therapy* / Q000473:pathology*; D006801:Humans; D008297:Male; D008533:Megakaryocytes / Q000187:drug effects* / Q000473:pathology*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010976:Platelet Count
D009173:Mycophenolic Acid